Closing the COVID-19 Test to Treatment Gap
Closing the COVID-19 Test to Treatment Gap
February 24, 2022 –
Understanding and knowing one’s COVID-19 status is critical to receiving timely treatment. The HHS Office of the Assistant Secretary for Preparedness and Response oversees the fair and equitable allocation and distribution of COVID-19 therapeutics under Emergency Use Authorization from the FDA. The window for treatment eligibility for these products is less than 10 days from symptom onset. Join us for a webinar to discuss the current COVID-19 therapeutics landscape and the best practices for helping close the test to treatment gap. The webinar will take place Thursday, February 24, 2022, from 2:00-3:00 PM ET.